151 related articles for article (PubMed ID: 10838548)
1. A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II : adaptation of the ecarin clotting time to the act II device.
Koster A; Loebe M; Hansen R; Bauer M; Mertzlufft F; Kuppe H; Hetzer R
J Thorac Cardiovasc Surg; 2000 Jun; 119(6):1278-83. PubMed ID: 10838548
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass--assessment of the whole blood ecarin clotting time.
Pötzsch B; Madlener K; Seelig C; Riess CF; Greinacher A; Müller-Berghaus G
Thromb Haemost; 1997 May; 77(5):920-5. PubMed ID: 9184403
[TBL] [Abstract][Full Text] [Related]
3. Hirudin monitoring using the TAS ecarin clotting time in patients with heparin-induced thrombocytopenia type II.
Koster A; Hansen R; Grauhan O; Hausmann H; Bauer M; Hetzer R; Kuppe H; Mertzlufft F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):249-52. PubMed ID: 10890474
[TBL] [Abstract][Full Text] [Related]
4. [Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].
Devignes J; de Maistre E; Grosjean S; Walter AF; Hacquard M; Mulot A; Longrois D; Carteaux JP; Lecompte T
Ann Biol Clin (Paris); 2005; 63(2):201-8. PubMed ID: 15771978
[TBL] [Abstract][Full Text] [Related]
5. Modified plasma-based ecarin clotting time assay for monitoring of recombinant hirudin during cardiac surgery.
Choi TS; Khan AI; Greilich PE; Kroll MH
Am J Clin Pathol; 2006 Feb; 125(2):290-5. PubMed ID: 16393689
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay.
Pötzsch B; Hund S; Madlener K; Unkrig C; Müller-Berghaus G
Thromb Res; 1997 Jun; 86(5):373-83. PubMed ID: 9211628
[TBL] [Abstract][Full Text] [Related]
7. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
Fabrizio MC
J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
[TBL] [Abstract][Full Text] [Related]
8. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
[TBL] [Abstract][Full Text] [Related]
9. Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
Sucker C; Zotz RB; Görlinger K; Hartmann M
Acta Anaesthesiol Scand; 2008 Mar; 52(3):358-62. PubMed ID: 18205897
[TBL] [Abstract][Full Text] [Related]
10. The use of ecarin chromogenic assay and prothrombinase induced clotting time in the monitoring of lepirudin for the treatment of heparin-induced thrombocytopenia.
Guy S; Kitchen S; Laidlaw S; Cooper P; Woolley A; Maclean R
Br J Haematol; 2008 Jul; 142(3):466-8. PubMed ID: 18510685
[TBL] [Abstract][Full Text] [Related]
11. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.
Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T
Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738
[TBL] [Abstract][Full Text] [Related]
12. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
13. Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: assessment of different filter systems.
Koster A; Merkle F; Hansen R; Loebe M; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
Anesth Analg; 2000 Aug; 91(2):265-9. PubMed ID: 10910829
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of hirudin therapy with the Thrombelastograph.
Pivalizza EG
J Clin Anesth; 2002 Sep; 14(6):456-8. PubMed ID: 12393117
[TBL] [Abstract][Full Text] [Related]
15. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients.
Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473
[TBL] [Abstract][Full Text] [Related]
16. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series.
Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ
Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban.
Koster A; Kukucka M; Bach F; Meyer O; Fischer T; Mertzlufft F; Loebe M; Hetzer R; Kuppe H
Anesthesiology; 2001 Feb; 94(2):245-51. PubMed ID: 11176088
[TBL] [Abstract][Full Text] [Related]
18. Successful use of recombinant hirudin and its monitoring by ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization.
Iqbal O; Tobu M; Aziz S; Gerdisch M; Da Valle M; Demir M; Hoppensteadt DA; Ahmad S; Walenga JM; Fareed J
J Card Surg; 2005; 20(1):42-51. PubMed ID: 15673409
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
Nowak G; Bucha E; Brauns I; Czerwinski R
Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia and the use of r-hirudin during cardiopulmonary bypass.
Manikappa S; Benfield K; Gan TE; Butler J; Malan E; Tran HA; Tucker A
Anaesth Intensive Care; 2005 Jun; 33(3):388-92. PubMed ID: 15973924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]